Bruker Corporation - Asset Resilience Ratio
Bruker Corporation (BRKR) has an Asset Resilience Ratio of 0.22% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Bruker Corporation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2023)
This chart shows how Bruker Corporation's Asset Resilience Ratio has changed over time. See Bruker Corporation balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Bruker Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BRKR company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $12.70 Million | 0.22% |
| Total Liquid Assets | $12.70 Million | 0.22% |
Asset Resilience Insights
- Limited Liquidity: Bruker Corporation maintains only 0.22% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bruker Corporation Industry Peers by Asset Resilience Ratio
Compare Bruker Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Bruker Corporation (2000–2023)
The table below shows the annual Asset Resilience Ratio data for Bruker Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.28% | $12.00 Million | $4.25 Billion | -2.49pp |
| 2022-12-31 | 2.77% | $100.00 Million | $3.61 Billion | +0.03pp |
| 2021-12-31 | 2.74% | $100.00 Million | $3.65 Billion | +1.10pp |
| 2020-12-31 | 1.64% | $50.00 Million | $3.05 Billion | +1.40pp |
| 2019-12-31 | 0.24% | $6.60 Million | $2.77 Billion | -- |
| 2018-12-31 | 0.00% | $0.00 | $2.13 Billion | -- |
| 2017-12-31 | 5.86% | $114.20 Million | $1.95 Billion | -2.85pp |
| 2016-12-31 | 8.71% | $157.90 Million | $1.81 Billion | -2.91pp |
| 2015-12-31 | 11.62% | $201.20 Million | $1.73 Billion | +2.08pp |
| 2014-12-31 | 9.55% | $178.00 Million | $1.86 Billion | +9.41pp |
| 2013-12-31 | 0.14% | $2.70 Million | $1.99 Billion | -0.06pp |
| 2012-12-31 | 0.20% | $3.70 Million | $1.86 Billion | +0.07pp |
| 2011-12-31 | 0.13% | $2.20 Million | $1.71 Billion | -0.06pp |
| 2010-12-31 | 0.19% | $2.90 Million | $1.55 Billion | +0.02pp |
| 2009-12-31 | 0.17% | $2.00 Million | $1.17 Billion | +0.04pp |
| 2008-12-31 | 0.13% | $1.50 Million | $1.12 Billion | -12.73pp |
| 2005-12-31 | 12.86% | $46.42 Million | $360.89 Million | +0.71pp |
| 2004-12-31 | 12.15% | $45.14 Million | $371.55 Million | +8.11pp |
| 2003-12-31 | 4.04% | $14.20 Million | $351.03 Million | -3.22pp |
| 2002-12-31 | 7.26% | $14.75 Million | $203.10 Million | -25.40pp |
| 2001-12-31 | 32.66% | $61.75 Million | $189.07 Million | -6.84pp |
| 2000-12-31 | 39.50% | $72.89 Million | $184.55 Million | -- |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more